1 week Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. Investor's Business Daily
Arcellx stock reversed lower Monday on positive results for its rival to Legend Biotech’s multiple myeloma treatment, Carvykti.
The post Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. appeared first on Investor's …